SPAR trial awarded $1.2m grant
The SPAR trial, which opened to recruitment in May this year, has received a $1.2 million grant from... Read More
Patient preferences for chemotherapy presented at ASCO
An AGITG sub-study presented at the world’s largest oncology meeting shows the way people with colorectal cancer make... Read More
The latest global developments in GI cancer from the ASCO Annual Meeting
More than 32,000 oncology professionals from around the world attended the ASCO Annual Meeting in June, presenting and... Read More
SCOT trial recognised for finding that chemotherapy courses could be halved
The SCOT trial is gaining international attention for its findings that three months of chemotherapy could be as... Read More
AGITG Trial News
Trial news: The AGITG currently has ten studies open to recruitment and ten studies in follow up. The table below... Read More
Summary of the 2018 Open Working Party Meetings
On 11 May, the AGITG held its Annual General Meeting coinciding with an Open Working Parties Meeting. The Working... Read More
Watch: Highlights of the Mt Aconcagua Gutsy Challenge
In December 2017, eight trekkers climbed Mt Aconcagua in Argentina to raise awareness and much-needed funds for digestive... Read More
2018 AGITG Innovation Fund – Open for Applications
The AGITG Innovation Fund is made possible through generous contributions from the Spencer Gibson Foundation, the... Read More
Worldwide call for all cancer patients to be prescribed exercise
The Clinical Oncology Society of Australia (COSA) has released a position statement on ‘Exercise in Cancer Care’. Highlighted... Read More
SPAR trial investigates the use of cholesterol medication in cancer treatment
The SPAR trial, which will test the effect of cholesterol medication on the treatment of patients with rectal... Read More
CONTROL NETs Recognised With $200,000 Grant
A $200,000 grant has been secured by the Unicorn Foundation for the CONTROL NETs study, which is providing... Read More
DYNAMIC-Rectal: Using blood tests to make chemotherapy decisions
The DYNAMIC-Rectal trial is currently in development. This trial will analyse the presence of circulating tumour DNA (ctDNA)... Read More
Dr Danielle Ferraro: How the Kristian Anderson Award enabled my research
Dr Danielle Ferraro from the University of Melbourne was the recipient of the inaugural Merck-AGITG Kristian Anderson Award... Read More
AGITG Outstanding Site Award
Clinical trial sites actively involved in AGITG Studies are invited to submit a brief application of 500 words... Read More
Applications are open for the 2018 Merck-AGITG Kristian Anderson Award
The Merck-AGITG Kristian Anderson Award supports a clinician undertaking a higher degree (MD or Ph.D) researching an aspect... Read More
The 2018 John Zalcberg OAM Award for Excellence in AGITG Research
The John Zalcberg OAM Award for Excellence in AGITG Research recognises a member of the Australasian Gastro-Intestinal Trials... Read More
Recruitment continues for NABNEC
Recruitment continues to progress for the NABNEC trial. The trial opened last year with participating centres in... Read More
Our new Research Fellow: Dr Sayeda Naher
At the beginning of February this year, the AGITG and GI Cancer Institute welcomed its newest Clinical Research... Read More
Colorectal Cancer Awareness Month: How our research contributes
Colorectal cancer is a cancer that starts in the colon or the rectum, when cells in the body... Read More
Employment Opportunities
The GI Cancer Institute is embarking on a program of significant growth over the next five years resulting... Read More